Small Molecule Drug Discovery Market Scope And Analysis

Report Code : TIPRE00004774
Category : Life Sciences

Status : Published
No. of Pages : 140

Buy Now

Small Molecule Drug Discovery Market Analysis, Size, and Growth (2023-2031)

Buy Now

Small Molecule Drug Discovery Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 50.93 Billion
Market Size by 2031	US$ 106.77 Billion
Global CAGR (2023 - 2031)	9.7%
Historical Data	2021-2022
Forecast period	2023-2031
Segments Covered	By Therapeutic Area Oncology Central Nervous System Cardiovascular Respiratory Orthopedics Immunology Rare Diseases Other Therapeutic Areas By Process/Phase Target Discovery Target Validation Lead Generation and Refinement Preclinical Development
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Bristol Myers Squibb Co Merck KGaA GSK Plc Boehringer Ingelheim International GmbH Thermo Fisher Scientific Inc ICON Plc Danaher Corp Charles River Laboratories International Inc Oncodesign Services Revvity Inc

Small Molecule Drug Discovery Market News and Recent Developments

The small molecule drug discovery market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

Oncodesign Services (ODS) acquired ZoBio, a Dutch CRO expert in biophysics-based small molecule drug discovery. This acquisition allows ODS to strengthen and extend its expertise and capabilities in the field of small molecule discovery to a fully integrated offering to support its customers' innovative programs from target validation to candidate selection. (Source: Oncodesign Services, Company Website, January 2024)
Merck entered into new strategic drug discovery collaborations aimed at harnessing powerful artificial intelligence (AI)-driven design and discovery capabilities, further advancing the company’s research efforts. The partnership of BenevolentAI (London, UK) and Exscientia (Oxford, UK) is expected to generate several novel clinical development drug candidates with first-in-class and best-in-class potential in key therapeutic areas of oncology, neurology, and immunology. (Source: Merck, Company Website, September 2023)

Small Molecule Drug Discovery Market Report Coverage and Deliverables

The "Small Molecule Drug Discovery Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

Small molecule drug discovery market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Small molecule drug discovery market trends, as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST and SWOT analysis
Small molecule drug discovery market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the small molecule drug discovery market
Detailed company profiles